Mimedx (MDXG) Shares Outstanding (Diluted Average) (2012 - 2026)

Mimedx's Shares Outstanding (Diluted Average) history runs 15 years deep, the most recent figure standing at $148.4 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) fell 0.82% year-over-year to $148.4 million; the TTM figure through Mar 2026 stood at $148.4 million (down 0.82% YoY), while the FY2025 annual figure was $149.7 million, changed 0.45% from the prior year.
• Shares Outstanding (Diluted Average) came in at $148.4 million for Q1 2026 at Mimedx, down from $149.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $150.0 million in Q1 2024 to a low of $111.6 million in Q1 2022.
• A 5-year average of $136.5 million and a median of $149.0 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• Across the five-year window, Shares Outstanding (Diluted Average) surged 32.02% in 2023 and slipped 0.82% in 2026, its largest moves.
• Mimedx's Shares Outstanding (Diluted Average) stood at $112.9 million in 2022, then grew by 29.27% to $146.0 million in 2023, then climbed by 2.11% to $149.0 million in 2024, then climbed by 0.45% to $149.7 million in 2025, then declined by 0.85% to $148.4 million in 2026.
• According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $148.4 million, $149.7 million, and $149.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison